PBM reform took a significant step forward this week as the U.S. House passed a federal funding bill that includes new ...

The House Appropriations Committee has unveiled proposed outlays for the Department of Health and Human Services, including key investments in priorities within the Make America Healthy Again movement ...

Pharmacy groups back PBM reforms in Medicare Part D to improve contract enforcement, appeals, and curb drug costs in the 2026 spending package.

Bill would prohibit PBM compensation in Medicare Part D from being tied to the manufacturer’s list price of a drug.

A renewal of the FDA’s pediatric rare disease voucher program is couched within a massive $1.2 trillion spending bill the ...

Retail pharmacies have been advocating for years for changes in the way PBMs operate, citing their opaque reimbursement ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

The PBM measures included in the bill have been championed by Earl L. “Buddy” Carter, a Republican from Georgia and pharmacist, who has long tried to pass legislation to address business practices of ...

TransparentRx shifts from PBM to PBA, giving employers and advisors direct control of pharmacy benefits through ...

CVS faces antitrust scrutiny over PBM practices allegedly pressuring independent pharmacies and blocking rivals.

The health department would get $116.8 billion in funding, a modest increase over 2025 but $33 billion more than Trump ...

Provisions targeting pharmacy benefit managers in a government funding agreement are poised to inject more transparency into ...